Shares of Medtronic (MDT) traded marginally lower on Thursday after rising from a low of $80.01 from the past six trading sessions, where shares soared overall ...
In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Medtronic (MDT – Research Report). The company’s ...
Medtronic said the Centers for Medicare & Medicaid Services is opening a coverage analysis on renal denervation for patients with hypertension that will include the review of its medical device. The ...
Medtronic plc (NYSE:MDT) develops, manufactures and sells device-based medical therapies to health care systems, physicians, clinicians and patients worldwide. It will report its Q3 2025 earnings on ...
Some results have been hidden because they may be inaccessible to you